Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Marksans Pharma Ltd

NSE: MARKSANS · BSE: 524404 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹336.95
Market cap: ₹15,269 Cr
Revenue (annual): ₹2,951 Cr
Net profit (annual): ₹417.9 Cr
P/E (TTM): 29.6×Sector 50.4×
Promoter holding: 43.87%+0.00% QoQ
FII holding: 17.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 2 Promoter Selling (Off-Market) 1 Other Announcement 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

12 Aug 2026 12:26 IST BSE

Financial Results

Marksans Pharma Q1 FY27 Results: Net Profit ₹159.4 Cr, Up 173.9% YoY

Marksans Pharma Ltd reported revenue from operations of ₹840.8 Cr (+35.6% YoY) and net profit of ₹159.4 Cr (+173.9% YoY) for Q1 FY27.

Key figure: Net profit ₹159.4 Cr · +173.9% YoY

Open full results → Read the filing ↗

26 May 2026 12:55 IST BSE

Financial ResultsAlfa Alert

Marksans Pharma Q4 FY26 Results: Net Profit ₹149 Cr, Up 64.3% YoY

Marksans Pharma Ltd reported revenue from operations of ₹856.1 Cr (+20.8% YoY) and net profit of ₹149 Cr (+64.3% YoY) for Q4 FY26.

Key figure: Net profit ₹149 Cr · +64.3% YoY

Open full results → Read the filing ↗